A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease

Erzhi pill (EZP), a classical traditional Chinese medicine prescription, exerts a potent hepatoprotective effect against metabolic dysfunction-associated fatty liver disease (MAFLD), previously known as nonalcoholic fatty liver disease (NAFLD). However, the mechanism and bioactive compounds underlyi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Res
Autors principals: Huang, Shaojie, Mu, Fei, Li, Fei, Wang, Wenjun, Chen, Haixia, Lei, Lu, Ma, Yang, Ding, Yi, Wang, Jingwen
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7382733/
https://ncbi.nlm.nih.gov/pubmed/32724826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7867245
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars